SEC Form 4 · accession 0001104659-17-003114
MARINUS PHARMACEUTICALS INC · MRNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Enrique J. Carrazana
Director
Period of report
Jan 17, 2017
Accepted (ET)
Jan 19, 2017 · 5:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267813
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $1.21 | Jan 17, 2017 | A | 66,500 | A | — | Jan 17, 2027 | Common Stock | 66,500 | 66,500 | D |
| Restricted stockF2,F3,F4 | — | Jan 17, 2017 | A | 28,500 | A | — | — | Common Stock | 28,500 | 28,500 | D |
Explanation of responses
- F1Options to purchase shares of common stock vest in 12 equal monthly installments commencing 1/31/17.
- F2Each share of restricted stock represents the right to receive, at settlement, one share of common stock.
- F3All shares of restricted stock vest on 1/17/18.
- F4Not applicable.